Literature DB >> 17462506

Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes.

Katsuaki Asano1, Hiroshi Ikegami, Tomomi Fujisawa, Masanori Nishino, Koji Nojima, Yumiko Kawabata, Shinsuke Noso, Yoshihisa Hiromine, Aya Fukai, Toshio Ogihara.   

Abstract

A recent study in the nonobese diabetic (NOD) mouse demonstrated the involvement of interleukin (IL)-21 in the pathogenesis of type 1 diabetes. A strong susceptibility locus, Idd3, has also been mapped to the interval containing the murine gene for IL-21 (Il21), making Il21 and the human orthologue IL21 a functional and positional candidate gene for type 1 diabetes. To investigate the contribution of the human genes for IL-21 and its receptor (IL-21R) to susceptibility to type 1 diabetes, we re-sequenced IL21 to identify novel sequence variants, searched for informative variants of IL21R, and studied the association of these variants with the disease. Two polymorphisms, a single nucleotide polymorphism (SNP) and a mononucleotide repeat polymorphism, were identified for IL21, and an allele of the mononucleotide repeat polymorphism was positively associated with the disease. Two novel microsatellite polymorphisms of IL21R were identified, one of which was associated with the disease. Scoring of individuals according to the status of these alleles showed a significant trend for high scores for susceptibility in diabetes patients, suggesting the contribution of IL21 and IL21R to disease susceptibility in an additive manner. These data suggest a contribution of IL21 and IL21R to genetic susceptibility to type 1 diabetes and possible involvement of IL-21 and its receptor system in the disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462506     DOI: 10.1016/j.humimm.2007.01.009

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  The 4q27 locus and prostate cancer risk.

Authors:  Elizabeth A Tindall; Hoa N Hoang; Melissa C Southey; Dallas R English; John L Hopper; Graham G Giles; Gianluca Severi; Vanessa M Hayes
Journal:  BMC Cancer       Date:  2010-02-25       Impact factor: 4.430

2.  ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes.

Authors:  Laura A Solt; Subhashis Banerjee; Sean Campbell; Theodore M Kamenecka; Thomas P Burris
Journal:  Endocrinology       Date:  2015-01-05       Impact factor: 4.736

Review 3.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

4.  Generation and characterization of human anti-human IL-21 neutralizing monoclonal antibodies.

Authors:  Mark F Maurer; Ursula Garrigues; Stephen R Jaspers; Brent Meengs; Mark W Rixon; Brenda L Stevens; Kenneth B Lewis; Susan H Julien; Thomas R Bukowski; Anitra C Wolf; Nels B Hamacher; Mark Snavely; Stacey R Dillon
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

5.  Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients.

Authors:  Hai-Feng Pan; Guo-Cui Wu; Yin-Guang Fan; Rui-Xue Leng; Hui Peng; Mo Zhou; Bao-Zhu Li; Yan Zhu; Jin-Hui Tao; Xiang-Pei Li; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-03-29       Impact factor: 2.631

6.  Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells.

Authors:  Ruddy Montandon; Sarantis Korniotis; Esther Layseca-Espinosa; Christophe Gras; Jérôme Mégret; Sophie Ezine; Michel Dy; Flora Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

7.  The PTPN22 1858T allele but not variants in the proximal promoter region of IL-21 gene is associated with the susceptibility to type 1 diabetes and the presence of autoantibodies in a Brazilian cohort.

Authors:  D T O Mainardi-Novo; A S Santos; R T Fukui; M Gamberini; M R S Correia; M O Ruiz; C L P Mangueira; S R Matioli; D M Vasconcelos; M E R Silva
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

8.  Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets.

Authors:  Tom L Van Belle; Stefan Nierkens; Ramon Arens; Matthias G von Herrath
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

Review 9.  Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus.

Authors:  Massimiliano Sarra; Giovanni Monteleone
Journal:  J Biomed Biotechnol       Date:  2010-06-28

10.  IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain.

Authors:  John S Tzartos; Matthew J Craner; Manuel A Friese; Karen B Jakobsen; Jia Newcombe; Margaret M Esiri; Lars Fugger
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.